Evidence map›Paper›PMID 33117328›Full record

ArticleFrontiers in immunology2020

Asymptomatic Infant With Atypical SCID and Novel Hypomorphic

Maria Chitty-Lopez, Emma Westermann-Clark, Irina Dawson, Boglarka Ujhazi, Krisztian Csomos, Kerry Dobbs, Khuong Le, Yasuhiro Yamazaki, Amir A Sadighi Akha, Deepak Chellapandian and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Maria Chitty-LopezDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Emma Westermann-ClarkDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Irina DawsonDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Boglarka UjhaziDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Krisztian CsomosDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Kerry DobbsLaboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, MD, United States.
Khuong LeLaboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, MD, United States.
Yasuhiro YamazakiLaboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, MD, United States.
Amir A Sadighi AkhaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Deepak ChellapandianCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Ben OshrineCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Luigi D NotarangeloLaboratory of Clinical Immunology and Microbiology, NIAID, National Institutes of Health, Bethesda, MD, United States.
Gauri SunkersettCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Jennifer W LeidingDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Jolan E WalterDivision of Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States.
Johns Hopkins University · USUniversity of South Florida · USJohns Hopkins All Children's Hospital · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USMayo Clinic in Arizona · US

Funding

Modeling and correcting human SCID using patient-derived iPS cellsR01AI100887 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MANIS, JOHN P · 2012 to 2020
$4.5M
NIAID NIH HHS R01 AI100887
6 · The paper itself

Abstract

The T-cell receptor excision circle (TREC) assay detects T-cell lymphopenia (TCL) in newborns and is especially important to identify severe combined immunodeficiency (SCID). A spectrum of SCID variants and non-SCID conditions that present with TCL are being discovered with increasing frequency by newborn screening (NBS). Recombination-activating gene (RAG) deficiency is one the most common causes of classical and atypical SCID and other conditions with immune dysregulation. We present the case of an asymptomatic male with undetectable TRECs on NBS at 1 week of age. The asymptomatic newborn was found to have severe TCL, but normal B cell quantities and lymphocyte proliferation upon mitogen stimulation. Next generation sequencing revealed compound heterozygous hypomorphic

Indexed as

Genetic VariationHematopoietic Stem Cell TransplantationNeonatal ScreeningAsymptomatic DiseasesGenetic Predisposition to DiseaseHomeodomain ProteinsHumansInfant, NewbornMalePhenotypePredictive Value of TestsSevere Combined ImmunodeficiencyTreatment OutcomeHomeodomain ProteinsRAG-1 proteinasymptomatic infantHSCTimmunodeficiencynewborn screeningrecombinase activating gene (RAG)SCID

Identifiers

PMID33117328
PMCPMC7552884
OpenAlexW3090880763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.